Results 241 to 250 of about 7,712,957 (388)

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

, 2004
Bertram L. Kasiske, Borja G. Cosío, Judith A. Beto, K Bolton, Blanche M. Chavers, Richard H. Grimm, Adeera Levin, Bassam A. Masri, Rulan S. Parekh, Christoph Wanner, David C. Wheeler, Peter W.F. Wilson   +11 more
openalex   +1 more source

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] [PDF]

, 2005
Jean‐Paul Ortonne, Neil H. Shear, Stephen Shumack, Eric Henninger   +3 more
openalex   +1 more source

Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction

Journal of the National Cancer Institute, 2018
R. Jagsi, Adeyiza O. Momoh, Ji Qi, J. Hamill, Jessica I Billig, Hyungjin Kim, A. Pusic, E. Wilkins   +7 more
semanticscholar   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Reconceptualizing Patient-reported Outcomes Measures in the Australian Breast Device Registry. [PDF]

Plast Reconstr Surg Glob Open
Herbert D, Ahern S, Walker M, Farrell G, Hopper I, Ruseckaite R.   +5 more
europepmc   +1 more source

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction (Report from the International EECP Patient Registry) [PDF]

, 2005
Özlem Soran, Elizabeth D. Kennard, Abdallah G. Kfoury, Sheryl F. Kelsey   +3 more
openalex   +1 more source

Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?

Molecular Oncology, EarlyView.
 
Chen‐xi Li, Zhong‐cheng Gong
wiley   +1 more source

The Effect of the Design of Polyethylene Inserts in Total Knee Arthroplasty on Patient Reported Outcomes. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Gunda B, Goldberg L, Alban A, Strecker S, McCracken C, Carangelo RJ, Witmer D.   +6 more
europepmc   +1 more source

Metaanalysis of the correlation between radiographic tumor response and patient‐reported outcomes [PDF]

, 2005
David Victorson, M. Soni, David Cella
openalex   +1 more source